Delving into the Latest Updates on Umbilical Cord Mesenchymal Stem Cells(Qingdao University) with Synapse

Overview

Basic Info

Drug Type

Mesenchymal stem cell therapy

Synonyms-

Target-

Action-

Mechanism

Cell replacements

Therapeutic Areas

Immune System DiseasesNervous System DiseasesCardiovascular Diseases+ [4]

Active Indication-

Inactive Indication

Cardiomyopathy, DilatedChronic Limb-Threatening IschemiaColitis, Ulcerative+ [4]

Originator Organization

Qingdao University

Active Organization-

Inactive Organization

Qingdao University

License Organization-

Drug Highest PhasePendingPhase 1/2

First Approval Date-

Regulation-

Login to view timeline

The main aim of the study is to determine whether intramuscular injection of umbilical cord mesenchymal stem cells can improve the ventricular function of children with idiopathic dilated cardiomyopathy(IDCM); Secondary end-points will be: 1)To explore the possible mechanism of the improvement of ventricular function in children with IDCM and 2) to evaluate the safety of intramuscular injection of umbilical cord mesenchymal stem cell.

Start Date01 Oct 2010

Sponsor / Collaborator

Qingdao University

NCT01221428

/ Unknown statusPhase 1/2IIT

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis

The purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of treatment for ulcerative colitis is safe and effective.

Start Date01 Sep 2010

Sponsor / Collaborator

Qingdao University

100 Clinical Results associated with Umbilical Cord Mesenchymal Stem Cells(Qingdao University)

Login to view more data

100 Translational Medicine associated with Umbilical Cord Mesenchymal Stem Cells(Qingdao University)

Login to view more data

100 Patents (Medical) associated with Umbilical Cord Mesenchymal Stem Cells(Qingdao University)

Login to view more data

100 Deals associated with Umbilical Cord Mesenchymal Stem Cells(Qingdao University)

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Chronic Limb-Threatening Ischemia	Phase 2	China	Qingdao University	01 Jan 2011
Diabetic Foot	Phase 2	China	Qingdao University	01 Jan 2011
Cardiomyopathy, Dilated	Phase 2	China	Qingdao University	01 Oct 2010
Fibrosis	Phase 2	China	Qingdao University	01 Oct 2010
Liver Cirrhosis	Phase 2	China	Qingdao University	01 Oct 2010
Colitis, Ulcerative	Phase 2	China	Qingdao University	01 Sep 2010
Diabetes Mellitus, Type 1	Phase 2	China	Qingdao University	01 Sep 2010